RIGEL PHARMACEUTICALS INC — Director's Dealing 2018

May 19, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RIGEL PHARMACEUTICALS INC (RIGL)
CIK: 0001034842
Period of Report: 2018-05-17

Reporting Person: Goodwin Bradford S (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-05-17	Stock Option (Right to Buy)	$3.98	A	40000	Acquired	2028-05-17	Common Stock (40000)	Direct

Footnotes

F1: The shares shall vest monthly over one (1) year from the date of grant subject to the reporting person's continuous service on the Company's Board of Directors.